
|Articles|August 15, 2022
Viral Vectors as a Gene Delivery Vehicle
Author(s)SGS
Innovations in the use of viral vectors as a gene delivery vehicle are a key factor in the growth of the gene and cell therapy field. However, the long-term impact of viral vectors requires continued research in their design to address both efficacy and the problems with immunogenicity and toxicity.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
3
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
4
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
5